ArticleLeukemia research2013

Cyclophosphamide, alvocidib (flavopiridol), and rituximab, a novel feasible chemoimmunotherapy regimen for patients with high-risk chronic lymphocytic leukemia.

Deborah M Stephens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.